ATXS

ATXS

USD

Astria Therapeutics Inc. Common Stock

$12.250+0.120 (0.989%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$12.130

高値

$12.390

安値

$12.110

出来高

1.43M

企業ファンダメンタルズ

時価総額

691.3M

業種

バイオテクノロジー

United States

取引統計

平均出来高

1.58M

取引所

NGM

通貨

USD

52週レンジ

安値 $3.555現在値 $12.250高値 $12.715

関連ニュース

BusinessWire

Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting

Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunologic diseases, today announced that it will present final results from the

もっと見る
Astria Therapeutics to Present at Upcoming American College of Allergy, Asthma, and Immunology Annual Scientific Meeting
PR Newswire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HOLX, TRUE, PCH, ATXS on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

もっと見る
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates HOLX, TRUE, PCH, ATXS on Behalf of Shareholders
Analyst Upgrades

JMP Securities Downgrades Astria Therapeutics to Market Perform

JMP Securities analyst Jonathan Wolleben downgrades Astria Therapeutics from Market Outperform to Market Perform.

もっと見る
JMP Securities Downgrades Astria Therapeutics to Market Perform
PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Astria Therapeutics, Inc. (NASDAQ: ATXS)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

もっと見る
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Astria Therapeutics, Inc. (NASDAQ: ATXS)
Analyst Upgrades

Jefferies Downgrades Astria Therapeutics to Hold, Lowers Price Target to $13

Jefferies analyst Eun Yang downgrades Astria Therapeutics from Buy to Hold and lowers the price target from $30 to $13.

もっと見る
Jefferies Downgrades Astria Therapeutics to Hold, Lowers Price Target to $13
PR Newswire

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ATXS, PCH, RYN on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PR Newswire

Shareholder Alert: The Ademi Firm investigates whether Astria Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

The Ademi Firm is investigating Astria (NASDAQ: ATXS) for possible breaches of fiduciary duty and other violations of law in its transaction with...